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ABSTRACT
Sperm agglutination antigen-1 (SAGA-1) is a human male
reproductive tract glycoform of CD52. Unique modification of
CD52 N-linked oligosaccharide chains in the epididymis and
vas deferens results in the appearance of a carbohydrate epi-
tope that is localized over the entire surface of human sper-
matozoa. SAGA-1 was characterized by the sperm-inhibitory
murine monoclonal antibody (mAb) S19, and it is the target
antigen of a human mAb (H6-3C4) associated with antibody-
mediated infertility. Collectively, sperm surface localization,
antibody inhibition of sperm function, and potential reproduc-
tive-tissue specificity identify SAGA-1 as an attractive candi-
date contraceptive immunogen. To establish an animal model
for the study of SAGA-1 in immunologic infertility and immu-
nocontraceptive development, we investigated the appearance
of the S19 carbohydrate epitope in nonhuman primates. The
S19 mAb demonstrated little to no immunoreactivity by West-
ern blot analysis with protein extracts of spermatozoa from the
baboon, marmoset, bonnet, cynomolgus, and pigtailed ma-
caques. Immunohistochemical analysis identified CD52 in the
bonnet monkey epididymis; however, the N-linked carbohy-
drate moiety recognized by the S19 mAb, and unique to SAGA-
1, was absent. In contrast, the S19 carbohydrate epitope was
identified in chimpanzee sperm extracts by Western blot anal-
ysis and in chimpanzee epididymal tissue sections by immu-
nohistochemical analysis, indicating that it is conserved in this
close relative of the human. Chimpanzee testis, seminal vesi-
cle, and prostate do not express the S19 epitope. Although
anti-CD52 immunoreactivity was identified in the spleen, the
carbohydrate moiety recognized by the S19 mAb was absent,
corroborating data in the human that demonstrated tissue-spe-
cific glycosylation of sperm CD52. Immunofluorescent analysis
indicated that the chimpanzee homologue of sperm CD52 was
present over the entire spermatozoon. In addition, the S19
mAb agglutinated chimpanzee spermatozoa in a manner sim-
ilar to the effect observed on human spermatozoa. These data
indicate that the distinctive carbohydrate moiety of human
sperm CD52 is present in the chimpanzee, and they identify
the chimpanzee as the most appropriate primate model to
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study the potential of this unique CD52 glycoform as a con-
traceptive immunogen.
epididymis, gamete biology, immunology, male reproductive
tract, sperm
INTRODUCTION
Identification of sperm antigens capable of eliciting pro-
duction of functionally relevant sperm antibodies is a first
step toward a more complete understanding of the mecha-
nism(s) underlying immunologic infertility. An antisperm
immune response is associated with up to 30% of couples
presenting with undefined infertility [1]. Immunodominant
sperm surface antigens relevant to antibody-mediated in-
fertility, although largely uncharacterized, display consid-
erable heterogeneity [2], perhaps reflecting diversity in the
mechanism(s) involved in disruption of the fertilization pro-
cess. Elucidation of the epitopes targeted by antisperm an-
tibodies would advance the diagnosis of immunologic in-
fertility and provide the basis for immunologic regulation
of fertility via a contraceptive vaccine.
Greater than 90% of extracellular membrane proteins in
all cell types are glycosylated [3], and the surface of mam-
malian sperm is no exception, being covered by a dense
glycocalyx (for review, see [4]). Monoclonal antibodies di-
rected against sperm surface molecules preferentially target
carbohydrate moieties [5, 6]. Moreover, the majority of
sperm-immobilizing antibodies in sera from infertile wom-
en were directed against carbohydrate epitopes of sperm
coating or sperm membrane antigens [7]. These findings
reflect the abundance and functional relevance of oligosac-
charides that collectively form the sperm glycocalyx. That
carbohydrate epitopes are often involved in eliciting anti-
sperm immune responses emphasizes the importance of the
chemical makeup of the glycocalyx in terms of understand-
ing and utilizing physiological responses of the immune
system during immunocontraceptive vaccine development.
Sperm agglutination antigen-1 (SAGA-1) is a highly
acidic (pI 2.5–3), polymorphic (;15–25 kDa) glycoprotein
secreted by the epididymis that is localized over the entire
human sperm plasma membrane [8]. SAGA-1 was identi-
fied as the target of an anticarbohydrate monoclonal anti-
body (mAb; H6-3C4) immortalized from an infertile wom-
an [9], linking this antigen to the cause of immunologic
infertility [10]. An mAb (S19) that displays multiple sperm-
inhibitory activities [8, 11, 12] recognizes a unique N-
linked glycan of SAGA-1 [10]. The peptide core of SAGA-
1 is identical to CD52, a glycosylphosphatidylinositol
(GPI)-anchored glycoprotein found on the surface of human
lymphocytes and spermatozoa. However, S19 immunore-
activity was identified only in the epididymis and on sper-
matozoa, indicating the S19 carbohydrate moiety was a
male reproductive tract-specific epitope [10]. Therefore,
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differential glycosylation of CD52 in the male reproductive
tract appears to result in the tissue-specific appearance of
an epitope that is the target of sperm-inhibitory mAbs. Col-
lectively, these results identify SAGA-1 as an attractive
candidate for development of an immunocontraceptive vac-
cine. Furthermore, a recombinant single-chain variable re-
gion fragment (ScFv) that reacts with SAGA-1 has been
engineered and may prove to be effective as a spermistatic
agent [13].
To establish a suitable animal model for the study of
SAGA-1 in immunologic infertility and contraceptive vac-
cine development, we examined expression of the S19 car-
bohydrate epitope in nonhuman primates. Sperm extracts
from a New World monkey (NWM; marmoset), Old World
monkeys (OWM; bonnet, pigtailed, cynomolgus, and ba-
boon), and a great ape (chimpanzee) were analyzed to de-
termine whether the carbohydrate moiety unique to SAGA-
1 was conserved among nonhuman primates. An anti-CD52
mAb, Campath-1M, was employed with the S19 mAb to
identify CD52 and potential tissue-specific glycoforms,
thereby distinguishing the presence or absence of the C-
terminal tripeptide/GPI-anchor of CD52 (the Campath-1M
epitope [14]) from differential glycosylation of CD52
among primates. Immunohistochemical analysis of repro-
ductive tissues and CD52-containing spleen tissue sections
was conducted to determine whether reproductive tract-spe-
cific modification of CD52 occurred in nonhuman primates,
as has been established in humans [10, 15]. Finally, func-
tional inhibition of spermatozoa by the S19 mAb identified
an appropriate primate model for the study of SAGA-1 in
contraceptive vaccine development.
MATERIALS AND METHODS
The University of Virginia Human Research Committee approved all
studies involving human semen donors. Informed consent was obtained
from each participant in the semen donor program after an explanation of
the nature and possible consequences of the studies. All procedures in-
volving the use of animals were conducted in accordance with the Guide
for Care and Use of Laboratory Animals (National Academy Press, Wash-
ington, DC).
Monoclonal Antibodies
The S19 mAb [11] (alternative nomenclature, MHS-8) directed against
SAGA-1 was generated by the immunization of mice with human sper-
matozoa as described previously [8]. Ascites fluid containing the S19 mAb
was also generated in mice as described previously [8]. For use in Western
blot, immunohistochemical, immunofluorescence, and agglutination anal-
yses, the S19 mAb was isolated by ammonium sulfate precipitation of
either ascites fluid or supernatants from in vitro cultures of the MHS-8
hybridoma. The Campath-1M mAb (rat immunoglobulin [Ig] M) was pur-
chased as clarified ascites from Serotec (Raleigh, NC). The H6-3C4 mAb
(human IgM), 2B6 (murine IgG3), 2C6 (murine IgM), and 2E5 (murine
IgG3) mAbs were generous gifts from Dr. Koji Koyama (Hyogo Medical
College, Nishinomiyz, Japan).
Preparation of Spermatozoa
Cynomolgus monkey (Macaca fascicularis) and pigtailed macaque (M.
nemestrina) spermatozoa were collected by electro-ejaculation and im-
mediately frozen or handled as described below. Bonnet monkey (M. ra-
diata) spermatozoa were generously provided by Dr. A.J. Rao from the
Primate Research Laboratory, and marmoset (Callithrix jacchus) sperma-
tozoa were a gift from the Wisconsin Regional Primate Research Center.
Baboon (Papio papio) spermatozoa were obtained from the Southwest
Foundation for Biomedical Research (San Antonio, TX). Ejaculated chim-
panzee (Pan troglodyte) spermatozoa were generously provided by the
Coulston Foundation (Alamogordo, NM) and the M.D. Anderson Cancer
Center (Bastrop, TX). Human semen, donated by healthy volunteers fol-
lowing 3 days of sexual abstinence, was washed following liquefaction at
room temperature, and spermatozoa were either extracted or frozen for
future use. Primate spermatozoa from the exudate of freshly collected ejac-
ulates were washed following liquefaction at room temperature. Frozen
ejaculates were thawed at 378C, and spermatozoa were pelleted by centri-
fugation at 400 3 g and washed in Ham F10 medium (Irvine Scientific,
Santa Ana, CA). Washed spermatozoa were fixed for immunofluorescent
analysis or extracted with 1% (w/v) SDS and centrifuged at 12 000 3 g
to remove insoluble debris. Protein concentrations of sperm extracts were
determined by BCA protein assay (Pierce Chemical, Rockford, IL) using
a BSA standard.
Polyacrylamide Gel Electrophoresis
and Western Blot Analysis
Polypeptides were separated by one-dimensional SDS-PAGE using
15% polyacrylamide gels [16] with equal amounts of total protein loaded
per lane. Benchmark prestained protein ladder (Gibco-BRL, Grand Island,
NY) standards were used to estimate the apparent molecular weight of
analyzed proteins. Proteins were electroblotted onto nitrocellulose [17],
and membranes were blocked for 30 min at room temperature in PBS
containing 0.05% (v/v) Tween-20 (PBS-T) and 5% (w/v) nonfat dry milk.
Western blots were incubated with primary antibody diluted in PBS-T/
0.5% nonfat dry milk. Primary antibody dilution factors were: S19, 1:
10 000; Campath-1M, 1:500; H6-3C4, 2B6, 2C6, and 2E5, 1:100. Blots
were washed 3 times with PBS-T and incubated with horse radish per-
oxidase (HRP)-conjugated goat anti-mouse, anti-rat, or anti-human im-
munoglobulin (1:5000; Jackson ImmunoResearch Laboratories, West
Grove, PA). Secondary antibodies alone served as negative controls. After
washing, blots were developed with TMB Membrane Peroxidase Substrate
(Kirkegaard & Perry Laboratories [KPL], Gaithersburg, MD).
Immunohistochemistry
Formalin-fixed, paraffin-embedded tissue sections from the reproduc-
tive tract (testis, epididymis, prostate, seminal vesicle) and spleen of the
chimpanzee were a generous gift from the Coulston Foundation. Tissue
from the caput, corpus, and cauda epididymis of the bonnet monkey were
obtained from the Primate Research Laboratory. Tissues were fixed in
neutral-buffered 10% (v/v) formalin (Sigma, St. Louis, MO), and fixed
tissues were embedded in paraffin and sectioned (thickness, 5 mm) at the
University of Virginia Cell Science Core. Following three 5-min washes
in xylene, tissue sections were rehydrated through descending amounts of
ethanol following the procedures of Southgate and Trejdosiewicz [18].
Slides were treated with 0.6% (v/v) H2O2/methanol for 10 min to abolish
endogenous peroxidase activity and washed in distilled H2O. Slides were
then washed in PBS for 10 min, and nonspecific protein-binding sites were
blocked by incubation in PBS with 10% (w/v) normal goat serum (NGS).
Tissue sections were incubated overnight at 48C in a humidified chamber
with null ascites or the S19 mAb (1:50) or Campath-1M mAb (1:100).
Following incubation, tissue sections were washed in PBS and incubated
for 1 h at room temperature with HRP-conjugated goat anti-mouse or anti-
rat antibodies for the S19 and Campath-1M mAbs, respectively (1:10 000;
Jackson ImmunoResearch Laboratories). Negative controls also included
secondary antibodies alone. To minimize the possibility of obtaining false-
negative results, antigen retrieval was attempted in tissues not displaying
immunoreactivity. Tissues were treated with 0.1% (w/v) trypsin in 0.1%
CaCl2 (pH 7.8) for 10 min at 378C, washed in PBS, and blocked with
10% NGS. Immunoreactivity was visualized with the TrueBlue reaction
substrate (KPL). Chimpanzee spleen sections were immunostained with
TrueBlue and counterstained with a nuclear fast red stain (Contrast Red;
KPL). Slides were observed by differential interference contrast (DIC)
microscopy, and images were recorded with a Zeiss Axioplan microscope
(Carl Zeiss, Inc., Thornwood, NY).
Immunofluorescence Microscopy
Freshly collected chimpanzee spermatozoa were fixed in 2% (w/v)
paraformaldehyde in PBS for 20 min, washed in PBS, and air-dried onto
poly-L-lysine-coated slides. Nonspecific protein-binding sites were blocked
by incubating in PBS with 10% (v/v) NGS for 30 min. Slides were in-
cubated with the S19 (1:100) or Campath-1M (1:100) mAb in PBS/1%
NGS for 1.5 h at room temperature. Slides were washed in PBS/1% NGS
and incubated for 1.5 h with fluorescein isothiocyanate-conjugated goat
anti-mouse IgG or goat anti-rat IgM (Jackson ImmunoResearch Labora-
tories) for the S19 and Campath-1M mAbs, respectively. Slides were
washed in PBS and mounted with SlowFade (Molecular Probes, Eugene,
OR). Secondary antibodies alone served as negative controls. Results were
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FIG. 1. Identification of the S19 mAb epitope in chimpanzee sperma-
tozoa. A Western blot of sperm extracts (100 mg/lane) from marmoset,
bonnet monkey, cynomolgus monkey, pigtailed macaque, baboon, chim-
panzee, and human was immunostained with the S19 mAb. A polymor-
phic antigen of similar molecular mass (;15–25 kDa) was identified in
chimpanzee and human spermatozoa.
FIG. 2. Immunohistochemical staining of formalin-fixed, paraffin-em-
bedded sections of the caput (Ct), corpus (Cr), and cauda (Cd) epididymis
of the bonnet monkey with the Campath-1M or the S19 mAb. Campath-
1M immunostained the luminal border, and the intensity of the staining
increased distally, with intense immunoreactivity in the cauda epididymis.
The S19 mAb failed to stain any region of the bonnet epididymis. Bar 5
25 mm.
visualized and recorded with a Zeiss Axiophot microscope (Carl Zeiss)
equipped for epifluorescence and DIC microscopy.
Sperm Agglutination Assay
The standard slide agglutination assay was performed as described by
Rose et al. [19] and modified by Diekman et al. [8]. Freshly collected
chimpanzee spermatozoa were diluted to 20 3 106 cells/ml in Ham F-10
medium and mixed with the S19 mAb purified from ascites fluid (1:5) or
with medium alone. Twenty microliters of the sperm solution were placed
on a Humagen (Humagen Fertility Diagnostics, Inc., Charlottesville, VA)
slide chamber, and sperm agglutination and motility were observed and
digitally recorded using DIC optics after 30 min at room temperature.
RESULTS
Evolutionarily Restricted Expression of the S19 Epitope
To examine relative expression of the S19 mAb carbo-
hydrate epitope among primate taxa, spermatozoa were col-
lected from NWM (marmoset), OWM (bonnet monkey, cy-
nomolgus macaque, pigtailed monkey, and baboon), and
great ape (chimpanzee), and expression of the S19 epitope
was analyzed by Western blot analysis (Fig. 1). The S19
mAb identified a polymorphic (;15–25 kDa) series of im-
munoreactive bands in chimpanzee sperm extracts that was
similar in molecular mass to SAGA-1 from human sper-
matozoa. In contrast, immunoreactivity corresponding to
the S19 carbohydrate moiety was absent from sperm ex-
tracts from NWM and most OWM (marmoset, bonnet mon-
key, pigtailed monkey, and baboon); weak S19 immuno-
reactivity was detected in cynomolgus sperm extracts. Sec-
ondary antibodies alone revealed no immunoreactivity
(data not shown). These data suggest that the S19 carbo-
hydrate epitope was conserved in chimpanzees but not in
lower-order primates.
Expression of CD52 Is Conserved in the Bonnet
Monkey Epididymis
To determine whether the failure to detect the S19 car-
bohydrate epitope in NWM and OWM could be due to
altered expression of CD52 and not differential glycosyla-
tion in those species, we examined expression of CD52 in
the caput, corpus, and cauda epididymis of the bonnet mon-
key with Campath-1M, an mAb directed against the C-ter-
minal tripeptide and the GPI-anchor of CD52 [14], and with
the S19 mAb. These two antibodies target completely dif-
ferent regions of CD52. Immunoreactivity with the Cam-
path-1M mAb is not dependent on the presence of specific
N-linked carbohydrate epitopes, but it is dependent on the
presence of conserved amino acid residues. Immunostain-
ing with the Campath-1M mAb revealed distinct regional
staining of the luminal border of the bonnet monkey epi-
didymis, the intensity of which increased distally, becoming
most prominent in the cauda epididymis (Fig. 2). However,
the S19 mAb, directed against an N-linked carbohydrate
epitope, failed to stain any region of the bonnet epididymis.
Secondary antibodies alone revealed no immunoreactivity
(data not shown).
Identification of the S19 carbohydrate moiety in chim-
panzee sperm extracts, but not in those from NWM and
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FIG. 3. Western blot of chimpanzee ejaculated sperm extracts (50 mg/
lane) immunostained with the S19, Campath-1M, 2B6, 2C6, 2E5, and H6-
3C4 mAbs. The Campath-1M, 2B6, 2C6, 2E5, and H6-3C4 antibodies
recognized a comparable set of polymorphic bands migrating between
approximately 18 and 22 kDa, slightly less heterogeneous in apparent
molecular mass compared to immunostaining with the S19 mAb.
FIG. 4. Immunohistochemical staining of formalin-fixed, paraffin-em-
bedded chimpanzee testis (A and E), epididymis (B and F), seminal vesicle
(C and G), and prostate (D and H) with the S19 mAb (A–D) or null ascites
(E–H). In the epididymis, immunoreactivity with the S19 mAb was ob-
served at the apical aspect of epithelial cells lining the lumen as well as
on spermatozoa within the lumen. Treatment with null ascites revealed
no immunoreactivity. Bar 5 50 mm.
OWM, despite identification of CD52 expression in the cy-
nomolgus monkey [20] and bonnet monkey, led us to an-
alyze in more detail the structural conservation of chim-
panzee CD52 with antibodies directed against portions of
its N-linked glycan or C-terminal tripeptide/GPI-anchor. In
addition to the S19 mAb, the Campath-1M and four other
mAbs (2B6, 2C6, 2E5, and H6-3C4) known to recognize
carbohydrate epitopes on CD52 were used to immunostain
Western blots of chimpanzee sperm extracts (Fig. 3). Re-
sults indicated that each mAb recognized a comparable set
of polymorphic bands in chimpanzee sperm extracts that
migrated between approximately 18 and 22 kDa, which is
slightly less heterogeneous in apparent molecular mass
compared to immunostaining with the S19 mAb. Secondary
antibodies alone revealed no immunoreactivity (data not
shown).
Expression of the S19 Epitope Is Restricted
to the Epididymis
Because an important criterion for a sperm-based con-
traceptive immunogen is tissue specificity, we investigated
expression of the S19 mAb carbohydrate epitope in various
chimpanzee reproductive tissues. Immunohistochemistry
was performed on formalin-fixed, paraffin-embedded testis,
seminal vesicle, prostate, and epididymal tissue sections us-
ing the S19 mAb and HRP-conjugated anti-mouse Ig (Fig.
4). Immunostaining revealed expression of the S19 mAb
epitope in the epididymis but not in the testis, seminal ves-
icle, or prostate tissue sections (Fig. 4, A–D). In the chim-
panzee epididymis, S19 immunoreactivity was identified at
the apical aspect of principal cells lining the lumen as well
as on spermatozoa within the lumen, similar to the expres-
sion pattern observed in the human epididymis [10]. A sim-
ilar pattern of immunoreactivity was observed in the chim-
panzee epididymis using the Campath-1M mAb (data not
shown). Tissue sections incubated with null ascites revealed
no immunoreactivity (Fig. 4, E–H).
To investigate whether the carbohydrate moiety ob-
served in the chimpanzee epididymis represented a tissue-
specific glycoform of CD52, formalin-fixed, paraffin-em-
bedded chimpanzee spleen tissue sections were incubated
with the anti-CD52 mAb Campath-1M or the S19 mAb,
immunostained with TrueBlue, and counterstained with
Contrast Red. The T cells at the periphery of the follicle
were immunostained by the Campath-1M mAb; however,
the germinal center, containing predominantly B cells, dem-
onstrated little to no immunoreactivity (Fig. 5A). No im-
munoreactivity was visible in the perifollicular zone or in
the germinal center of spleen sections incubated with the
S19 mAb (Fig. 5B) or with secondary antibodies alone
(Fig. 5, C and D), indicating that the S19 mAb epitope
identified on chimpanzee sperm CD52 was not expressed
in the chimpanzee spleen. Therefore, the S19 carbohydrate
epitope may represent a male reproductive tract-specific
product.
Localization of the S19 Epitope and Functional Inhibition
of Chimpanzee Spermatozoa
Indirect immunofluorescent analysis was performed on
paraformaldehyde-fixed chimpanzee sperm to determine
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FIG. 5. The S19 epitope is absent from CD52 in chimpanzee lymphoid
organs. Formalin-fixed, paraffin-embedded chimpanzee spleen tissue sec-
tions were immunostained with the Campath-1M (A) or S19 mAb (B) and
counterstained with a nuclear fast red stain (Contrast Red). The T cells at
the periphery of the follicle were immunostained by the Campath-1M
mAb; however, the germinal center, containing predominantly B cells,
demonstrated little staining. No immunoreactivity was visible with the
S19 mAb. Secondary antibody controls for the Campath-1M and S19
mAbs (C and D, respectively) showed no immunoreactivity. Bar 5 10
mm.
FIG. 6. Indirect immunofluorescent stain-
ing of paraformaldehyde-fixed chimpanzee
spermatozoa with the mouse S19 mAb (A)
and the rat Campath-1M mAb (B). Immu-
nofluorescence was observed over the en-
tire surface of chimpanzee sperm stained
with both antibodies. No immunofluores-
cent staining was observed with secondary
anti-mouse (C and D) and anti-rat (E and
F) antibody-negative controls. Both immu-
nofluorescence (A–C and E) and DIC mi-
croscopy (D and F) are shown. Bar 5 10
mm.
whether the S19 epitope was localized on the entire chim-
panzee sperm surface, as it is in the human [8]. Similar to
the human, both the S19 and Campath-1M mAbs bound to
chimpanzee sperm, with fluorescence localized over the en-
tire cell (Fig. 6, A and B). Secondary antibodies alone re-
vealed no staining (Fig. 6, C–F).
To assess the inhibitory activity of the S19 mAb on
chimpanzee spermatozoa, agglutination analysis was per-
formed with freshly collected chimpanzee semen. Semen
was diluted in Ham F10 media and mixed with an equal
volume of medium alone (Fig. 7A) or the S19 mAb (Fig.
7B) and then incubated at room temperature. Agglutination
was observed as the cross-linking or clumping together of
spermatozoa only in the S19 mAb-treated sample, indicat-
ing that the carbohydrate moiety is present on the surface
of chimpanzee spermatozoa and is accessible to functional
inhibition by the S19 mAb.
DISCUSSION
This comparative study of expression of CD52 and a
unique N-linked epitope on CD52, SAGA-1, using semen
from NWM, OWM, and a great ape indicated that a unique
carbohydrate moiety of human CD52 was conserved in the
chimpanzee. Little or no immunoreactivity corresponding
to the carbohydrate epitope was apparent in NWM or
OWM. Western blot analysis performed with a panel of
previously characterized mAbs known to recognize oligo-
saccharide epitopes on human CD52 indicated that the N-
linked glycan, including the S19 epitope present on a hu-
man sperm-specific glycoform of CD52, was highly con-
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FIG. 7. Functional inhibition of chimpanzee spermatozoa by the S19
mAb. Live chimpanzee spermatozoa were diluted in Ham F10 media and
mixed with an equal volume of medium alone (A) or the S19 mAb (B),
and sperm motility was observed. Agglutination in a tangled pattern was
observed only in the sample treated with the S19 mAb. Bar 5 100 mm.
served in chimpanzee spermatozoa. The S19 epitope has
been localized over the entire human sperm surface by im-
munofluorescence and ultrastructural analysis [21]. In the
present study, the S19 epitope localized to the entire surface
of chimpanzee spermatozoa, rendering cells susceptible to
agglutination on exposure to the anti-SAGA-1 S19 mAb.
Investigation of the apparent hominid-specific expression of
the S19 epitope identified differential expression of the
Campath-1M and S19 epitopes in the bonnet epididymis.
Although CD52 was expressed in the epididymis of the
bonnet monkey, the glycoform of CD52 recognized by the
S19 mAb was not detected in parallel tissue sections or on
Western blots of bonnet sperm extracts. Therefore, despite
conservation of the C-terminal tripeptide/GPI-anchor of
CD52, the unique glycosylation of CD52 with concomitant
expression of the S19 mAb carbohydrate epitope that is
apparent in humans and chimpanzees was not conserved in
the OWM. Collectively, these results indicated that the car-
bohydrate epitope recognized by the S19 mAb either was
not as abundant or was not structurally conserved in NWM
or OWM relative to the chimpanzee or human.
In the chimpanzee, expression of the S19 epitope was
identified in the epididymis but not in the testis, seminal
vesicles, or prostate, similar to immunohistochemical and
Western blot data from the human (unpublished data). Ep-
ididymal localization of the S19 mAb epitope in chimpan-
zees was identical to localization in the human epididymis
[10]. The S19 immunoreactivity was identified on the mi-
crovilli of epithelial cells surrounding the epididymal lumen
and on spermatozoa in the lumen. In addition, immunohis-
tochemical analysis of expression of CD52 and its unique
N-linked glycan demonstrated that the carbohydrate epitope
recognized by the S19 mAb was not present in the chim-
panzee spleen despite expression of CD52. Combined with
the finding that S19 epitope was expressed in the epididy-
mis but not in other male reproductive tissues tested, these
data indicate that a tissue-specific CD52 glycoform is ex-
pressed in the chimpanzee, and they corroborate data in the
human that identified a CD52 glycoform [10] that appears
to be a male reproductive tract-specific product.
To evaluate the potential use of an antigen as a contra-
ceptive agent, it is preferable to identify a nonhuman pri-
mate model system possessing a homologue of the given
antigen. Although a number of mammalian homologues of
CD52 are known [22, 23], these sequences are similar only
in their signal sequences and not in the core peptide. More-
over, the present study highlights the importance of post-
translational modification of sperm surface CD52 with re-
spect to identification of a nonhuman primate model ex-
pressing a homologue to this defined glycoprotein. CD52
was identified in the bonnet epididymis, but the CD52 gly-
coform recognized by the S19 mAb was not detected. The
S19 immunoreactivity was not present in NWM or OWM
but was identified in the chimpanzee epididymis and on
chimpanzee spermatozoa.
Carbohydrate moieties on sperm surface glycoproteins
may be added or exposed during sperm maturation [24–27]
and/or capacitation [28]. Glycosylated GPI-anchored sperm
proteins such as CD59 [29], CD55 [30], and CD52 [28, 31,
32] are secreted by the epididymal epithelium and inserted
into the sperm membrane during epididymal transit [33,
34]. The S19 carbohydrate epitope is acquired on the sperm
surface during transit of spermatozoa through the epididy-
mis, and a concomitant increase in heterogeneity of S19
immunoreactivity accompanies sperm migration through
the caput, corpus, and cauda epididymidal regions (unpub-
lished data). The regulation of cell-specific and tissue-spe-
cific glycans has been attributed to the presence and activity
of glycosyltransferases (for review, see [35]), many of
which display unique tissue distribution and substrate spec-
ificity [36]. Although only speculative at this time, identi-
fication of an apparently tissue-specific S19 carbohydrate
epitope on CD52 in chimpanzees and humans suggests that
a unique glycosyltransferase either exists in the epithelium
or lumen of the hominid epididymis or is uniquely regu-
lated by the epididymal environment. Alternatively, expo-
sure to glycosidase or protease activity may contribute to
appearance of the S19 epitope. Although epididymal epi-
thelial cell culture has been moderately successful in a va-
riety of species [37–40], including the human [41], devel-
opment of an improved, more stable epididymal cell culture
system would enhance efforts directed at the identification
of glycosyltransferase activity potentially responsible for
expression of the unique sperm surface S19 epitope.
Schro¨ter et al. [15] demonstrated that more than 50 dif-
ferent N-linked oligosaccharide structures were present in
human seminal plasma CD52, a much higher degree of het-
erogeneity compared to the carbohydrate structures identi-
fied in spleen CD52 [42]. These data underscore the need
to characterize carbohydrate epitopes potentially viewed as
targets for immunocontraceptive development. Target epi-
topes for immunocontraceptive development should be
sperm-specific to prevent harmful cross-reactivity with so-
matic tissues. For example, unlike the anticarbohydrate
2B6, 2C6, and 2E5 mAbs, the S19 mAb epitope appears
to be specific to a sperm glycoform of human CD52 [10],
diminishing possible concerns regarding induction of au-
1687CHIMPANZEE SAGA-1
toimmune disease in SAGA-1 immunogenicity studies due
to cross-reactive somatic tissues.
The principal finding of the present study is that a unique
glycoform of CD52 is structurally conserved in chimpan-
zees but not in lower-order nonhuman primates, identifying
the chimpanzee as an appropriate nonhuman primate model
to advance immunocontraceptive vaccine development of
SAGA-1. Of particular interest is that humans are most
closely related to the chimpanzee, sharing approximately
99% genetic identity [43–46]. Thus, it is reasonable to
speculate that an evolutionary event may have occurred af-
ter divergence of hominids from the OWM some 31 million
years ago [46] that led to the expression of a unique car-
bohydrate epitope in the epididymis. That such an evolu-
tionary event could have altered the structure of the N-
linked glycan of CD52 is supported by the example of loss
of expression in humans of a carbohydrate epitope (N-gly-
colylneuraminic acid) common in all other mammals, in-
cluding the great apes [47]. One would expect to find few
genetic differences between chimpanzees and humans, yet
a mutation in human cytidine monophospho-sialic acid hy-
droxylase led to the lack of expression in humans of a com-
mon type of sialic acid found in chimpanzees. Accelerated
evolution of male reproductive genes has been noted in
primates and in the lineages leading to both the chimpanzee
and human [48]; thus, the expression of a carbohydrate epi-
tope on spermatozoa from chimpanzees and humans, but
not from other primates, may be linked to an evolutionary
change related to glycan synthesis. Because of the lack of
conserved expression in other primates, the most informa-
tive preclinical studies regarding the immunogenic and con-
traceptive potential of SAGA-1 would derive from inves-
tigations using the chimpanzee primate model.
To our knowledge, differences in sperm surface carbo-
hydrates have not been previously demonstrated among pri-
mates. As more knowledge is gained regarding the role of
such carbohydrates in sperm function, it will be important
to test if such differences relate to primate speciation.
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